Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinoma.

Saved in:
Bibliographic Details
Title: Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinoma.
Authors: Torasawa M; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan. Electronic address: tatyoshi@ncc.go.jp., Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Yagishita S; Division of Molecular Pharmacology, National Cancer Center Research Institute, Tokyo, Japan., Ono H; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Uehara Y; Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan; Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan., Miyakoshi J; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Tateishi A; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Igawa YS; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Higashiyama RI; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Mochizuki A; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Masuda K; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Matsumoto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Shinno Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Okuma Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Goto Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Horinouchi H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan., Hamamoto R; Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo, Japan., Yamamoto N; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan., Watanabe SI; Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, Japan., Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan., Takahashi K; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan., Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, Japan., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Source: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2025 Apr; Vol. 202, pp. 108494. Date of Electronic Publication: 2025 Mar 11.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8332 (Electronic) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-8332
DOI:10.1016/j.lungcan.2025.108494